age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
84.62695
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 13
| null | 0
| 7,392
| 6,289.4883
| 5,005.32812
| 11.5
|
white
| 15.798828
| 31
| 0.849976
| 0.75293
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 13
| 71
| 11.398438
| 70
| 24
| 36.79688
| null | 3.899902
| 0.199982
| 1.799805
| 134
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 582
| 1
|
88.17499
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 6
|
under $11k
| 0
| 5,614
| 4,470.8594
| 3,149.31836
| 13.5
|
white
| 15.599609
| 45
| 0.840942
| 0.738892
| 1
| 1
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 8
| 76
| 7.599609
| 64
| 28
| 35.79688
| 237.5
| 4.299805
| 0.399963
| 1.799805
| 137
| 7.449219
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 385
| 1
|
74.125
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 37,841
| 27,540.0938
| 24,555.875
| 19
|
white
| 21.097656
| 17
| 0.73291
| 0.580933
| 24
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 5
| 77
| 8.898438
| 60
| 24
| 36.29688
| 404
| 2.599609
| 0.5
| 0.899902
| 139
| 7.279297
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,237
| 1
|
60.20798
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| null | null | 0
| 2,978
| 1,929.8897
| 2,192.82812
| 11
|
white
| 11.699219
| 19
| 0.806885
| 0.588989
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
no dnr
| 5
| 102
| 1.399902
| 114
| 20
| 36.89844
| 354.25
| 4.199219
| 0.5
| 0.599976
| 137
| 7.489258
| null | null | null | null | null | null | 2.162598
| 147
| 1
|
78.49396
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 2,454
| 1,688.2568
| 1,355.39941
| 11
|
white
| 18.796875
| 23
| 0.832886
| 0.727905
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 5
| 71
| 12.798828
| 66
| 24
| 36.19531
| null | null | null | 1.599854
| 140
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
74.146
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 26
| 19,965
| 15,764.0625
| 14,631.1797
| 27
|
white
| 36.398438
| 45
| 0.274963
| 0.166992
| 1
| 0
| 0
|
yes
| 0.15
| 0.1
|
dnr after sadm
| 2
| 106
| 24.898438
| 114
| 10
| 35.29688
| 147.5
| 3.099609
| 0.599976
| 3.399902
| 132
| 7.449219
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
69.40198
|
male
| 0
| 56
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 12
|
$25-$50k
| 0
| 75,868
| 49,369.375
| 48,814.5312
| 22.5
|
white
| 30.398438
| 56
| 0.674927
| 0.503906
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 56
| 73
| 9.099609
| 60
| 10
| 35.5
| 153.84375
| null | 4.099609
| 2.599609
| 143
| 7.279297
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 116
| 1
|
78.78998
|
male
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 44
| 87,229
| 58,370.875
| 53,972
| 36
|
white
| 31.199219
| 52
| 0.314941
| 0.201996
| 5
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 39
| 68
| 21
| 40
| 12
| 38.19531
| 163.0625
| 3.199707
| 2
| 3.899902
| 135
| 7.319336
| null | null | null | null | 1
| null | 1
| 1,552
| 0
|
76.71198
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 9
| 30,223
| 22,569.3125
| 17,698.5469
| 17.333328
|
white
| 28.898438
| 65
| 0.553955
| 0.441956
| 8
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 16
| 59
| 16.796875
| 72
| 32
| 35.89844
| 126.51562
| null | null | 11.599609
| 145
| 7.419922
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 669
| 1
|
75.849
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 133,616
| 93,028.6875
| 77,854.625
| 53.666657
|
white
| 30.796875
| 60
| 0.535889
| 0.421997
| 13
| 0
| 0
|
no
| null | null |
dnr after sadm
| 18
| 56
| 21.898438
| 112
| 24
| 39.19531
| 189
| null | null | 5.699219
| 138
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.270508
| 19
| 1
|
70.35199
|
female
| 0
| 19
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 30,342
| 19,691.1719
| 17,380.3281
| 23
|
white
| 13.798828
| 35
| 0.903931
| 0.837891
| 1
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 19
| 79
| 9.798828
| 69
| 26
| 35.89844
| null | 4.199219
| 0.199982
| 1.199951
| 134
| null | null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,360
| 1
|
50.23999
|
female
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 138,255
| 92,819.25
| 102,443.938
| 38.25
|
white
| 28.097656
| 30
| 0.716919
| 0.630981
| 62
| 0
| 0
|
no
| null | null |
dnr after sadm
| 27
| 119
| 2
| 108
| 34
| 39.39844
| 187.5
| null | null | 1.099854
| 143
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
67.38898
|
male
| 0
| 17
|
MOSF w/Malig
|
ARF/MOSF
| 4
| 8
|
under $11k
| 61
| 51,502
| 36,644.375
| 31,339.8281
| 17
|
white
| 21.699219
| 45
| 0.280945
| 0.171997
| 15
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 107
| 15
| 36
| 30
| 38.09375
| 214.28125
| null | null | 1
| 133
| 7.489258
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 27
| 1
|
68.92297
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 0
| 2,206
| 1,526.5645
| 1,304.58984
| 3
|
white
| 18.898438
| 34
| 0.861938
| 0.770996
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 111
| 6.399414
| 42
| 29
| 36.59375
| 271.375
| 3.899902
| 1.199951
| 1.5
| 137
| 7.459961
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.032715
| 1,549
| 0
|
71.50995
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 20,986
| 13,111.0078
| 11,977.3672
| 22.5
|
white
| 15.5
| 28
| 0.886963
| 0.81189
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 68
| 7.5
| 65
| 20
| 36.19531
| 493.3125
| 3.799805
| 0.5
| 1.599854
| 136
| 7.549805
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,547
| 0
|
75.22198
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 44,402
| 28,899.2344
| 27,155.0156
| 35.5
|
white
| 17
| 22
| 0.862915
| 0.814941
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 25
| 64
| 11.099609
| 75
| 10
| 38
| 186.65625
| 3.199707
| 0.5
| 1
| 134
| 7.509766
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 724
| 1
|
79.36499
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 0
| 83,102
| 63,425.4688
| 50,705.875
| 18
|
white
| 20.796875
| 27
| 0.736938
| 0.654907
| 19
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 33
| 70
| 23
| 72
| 28
| 36.29688
| 360
| null | null | 1.699951
| 141
| 7.449219
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 715
| 1
|
49.80399
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 17
|
$25-$50k
| 0
| 2,533
| 1,633.0664
| 1,550.70996
| 13
|
white
| 12.798828
| 13
| 0.80896
| 0.590942
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 103
| 6.399414
| 79
| 20
| 36.39844
| null | 3.599609
| 0.299988
| 1
| 135
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.041992
| 84
| 1
|
53.39398
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,540
| 2,517.4844
| 2,616.35938
| 9
|
white
| 8.099609
| 11
| 0.860962
| 0.688965
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 93
| 5.899414
| 98
| 20
| 36.39844
| null | 4.399414
| 0.299988
| 0.699951
| 133
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.732666
| 325
| 1
|
65.79297
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,527
| 1,990.7373
| 1,217.95996
| 13
|
white
| 11.099609
| 11
| 0.805908
| 0.586914
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 93
| 15.5
| 76
| 20
| 36.59375
| null | 3.899902
| 0.699951
| 1.199951
| 136
| null | null | null | null | null | null | null | 1.825928
| 161
| 1
|
90.79297
|
female
| 1
| 6
|
Coma
|
Coma
| 2
| null | null | 61
| 5,507
| 3,241.8184
| 2,811.71875
| 30
|
white
| 21.296875
| 48
| 0.145996
| 0.094986
| 1
| 1
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 1
| 55
| 7.599609
| 45
| 32
| 37.89844
| 319
| null | null | 1.299805
| 139
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 3.229004
| 6
| 1
|
78.25098
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 16
|
$11-$25k
| 0
| 11,474
| 7,410.6758
| 6,662.26953
| 7.5
|
white
| 11.298828
| 22
| 0.780884
| 0.541992
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 11
| 118
| 16.796875
| 85
| 20
| 35.89844
| null | 4.099609
| 0.599976
| 1.399902
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 109
| 1
|
53.46997
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
under $11k
| 26
| 49,510
| 32,146.2031
| 24,283.3125
| 33
|
white
| 39.59375
| 82
| 0.28595
| 0.176971
| 23
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 64
| 22.199219
| 158
| 37
| 37.79688
| 101.25
| 2.699707
| 8.398438
| 1.5
| 132
| 7.369141
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
52.80798
|
male
| 0
| 20
|
Coma
|
Coma
| 5
| null | null | 61
| 50,898
| 34,947.625
| 30,141.4375
| 36.666657
|
white
| 26.597656
| 35
| 0.35199
| 0.278992
| 10
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 13
| 66
| 14.898438
| 166
| 10
| 39.59375
| 151.40625
| 3.199707
| 1.599854
| 1.099854
| 135
| 7.609375
| null | null | null | null | null |
<2 mo. follow-up
| 3.814941
| 27
| 1
|
69.22095
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
under $11k
| 41
| 20,614
| 13,453.0234
| 12,593.8047
| 23
|
white
| 23.699219
| 30
| 0.530884
| 0.415955
| 5
| 0
| 0
|
yes
| 0.95
| 0.8
|
no dnr
| 11
| 77
| null | 72
| 40
| 36.19531
| 160
| 3.099609
| 1.199951
| 0.699951
| 134
| 7.439453
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,160
| 1
|
71.88794
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 5,793
| 3,965.2519
| 3,502.97852
| 6.5
|
white
| 22.699219
| 35
| 0.805908
| 0.68689
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
no dnr
| 9
| 63
| 7.699219
| 46
| 32
| 36
| 342.8125
| null | null | 1.699951
| 139
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,531
| 0
|
77.35199
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 15
|
$25-$50k
| 0
| 3,522
| 2,367.6758
| 1,914.67969
| 18
|
white
| 16.796875
| 23
| 0.825928
| 0.715942
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 7
| 113
| 7.899414
| 76
| 24
| 36.09375
| 356
| 3.199707
| 0.599976
| 1.299805
| 140
| 7.469727
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 388
| 1
|
60.56897
|
female
| 0
| 80
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 123,165
| 83,129.6875
| 75,931.75
| 10.75
|
white
| 31.796875
| 60
| 0.559937
| 0.447998
| 15
| 0
| 0
|
no
| null | null |
no dnr
| 80
| 63
| 26.097656
| 122
| 28
| 38.29688
| 150
| null | null | 6
| 143
| 7.379883
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,531
| 0
|
71.45795
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 7,726
| 5,278.8398
| 4,269.61719
| 11.5
|
white
| 20.097656
| 26
| 0.80188
| 0.680908
| 1
| 0
| 0
|
yes
| 0.75
| 0.65
|
no dnr
| 13
| 68
| 9.199219
| 102
| 24
| 35.5
| 452.375
| 3.699707
| 1.199951
| 1.399902
| 134
| 7.549805
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,530
| 0
|
78.20398
|
female
| 0
| 36
|
Coma
|
Coma
| 2
| 12
| null | 44
| 91,560
| 62,189.1875
| 56,398.2812
| 25.75
|
white
| 20.699219
| 41
| 0.362
| 0.28894
| 8
| 1
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 36
| 117
| 14.199219
| 70
| 55
| 39.09375
| 255
| null | null | 1.5
| 141
| 7.459961
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 412
| 1
|
63.32098
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 32,987
| 21,631.4844
| 20,892.9375
| 44
|
white
| 39.898438
| 59
| 0.167999
| 0.084991
| 15
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 77
| 0.199982
| 132
| 28
| 36.39844
| 104.07812
| null | null | 1.5
| 136
| 7.289062
| null | null | null | null | null |
<2 mo. follow-up
| 2.152344
| 5
| 1
|
68.11798
|
male
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 7
| 8
|
under $11k
| 9
| 18,851
| 12,522.1797
| 10,364.0391
| 15.666664
|
white
| 33
| 67
| 0.53894
| 0.339966
| 4
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 56
| null | 68
| 32
| 34.79688
| 112.5
| 3.899902
| 0.899902
| 1.599854
| 128
| 7.529297
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 20
| 1
|
64.99695
|
male
| 0
| 12
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 0
| 9,728
| 6,943.918
| 6,049.35938
| 14.5
|
white
| 18.097656
| 35
| 0.791992
| 0.665894
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 12
| 106
| 18.699219
| 80
| 32
| 36.59375
| 308.6875
| 2.599609
| 0.699951
| 1.5
| 142
| 7.449219
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 86
| 1
|
71.99695
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 62,426
| 43,641
| 35,937.8125
| 53
|
white
| 34.59375
| 55
| 0.19397
| 0.102997
| 40
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 50
| 10.699219
| 132
| 34
| 37.89844
| 108.15625
| 3.399902
| 0.599976
| 1.199951
| 137
| 7.179688
| null | null | null | null | null |
<2 mo. follow-up
| 2.531738
| 7
| 1
|
42.77298
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 8,097
| 4,892.0781
| 4,218.04688
| 10.5
|
white
| 22.699219
| 24
| 0.881958
| 0.840942
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 8
| 81
| 14.898438
| 76
| 36
| 38.09375
| 135
| 4
| 0.5
| 0.899902
| 134
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,528
| 0
|
76.53894
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 5,133
| 3,023.4414
| 3,598.87891
| 7
|
white
| 11
| 21
| 0.86792
| 0.704956
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 4
| 111
| 11.699219
| 53
| 20
| 36.69531
| null | 4.199219
| 0.599976
| 1.5
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 824
| 1
|
67.32397
|
female
| 0
| 15
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 30,640
| 20,329.25
| 18,136.3906
| 10.666664
|
white
| 30.398438
| 39
| 0.393982
| 0.196991
| 14
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 14
| 63
| 13
| 76
| 22
| 36.69531
| null | null | null | 4.399414
| 121
| null | null | null | null | 2
| 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
53.00998
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 2
| 10
| null | 0
| 9,445
| 5,743.1953
| 5,586.60938
| 8.5
|
white
| 18.296875
| 35
| 0.710938
| 0.428955
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 8
| 67
| 0.199982
| 66
| 24
| 38.69531
| null | 3.399902
| 1.199951
| 1.199951
| 129
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 3.136719
| 249
| 1
|
72.51996
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 8
|
under $11k
| 0
| 12,209
| 8,282.5
| 6,967.95703
| 17
|
white
| 19.597656
| 57
| 0.832886
| 0.726929
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 13
| 61
| 9.099609
| 75
| 36
| 36.5
| 186.9375
| 4.099609
| 0.399963
| 2.199707
| 148
| 7.369141
| null | null | null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 1,040
| 1
|
61.19598
|
male
| 0
| 150
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 304,423
| 202,078.875
| 207,309
| 35.25
|
white
| 44.5
| 64
| 0.241974
| 0.139984
| 12
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 150
| 42
| 13.898438
| 144
| 28
| 38.69531
| 92
| 2.899902
| 1.399902
| 1.5
| 133
| 7.699219
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,021
| 1
|
67.64697
|
male
| 0
| 42
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 0
| 87,706
| 55,599.4062
| 53,503.0625
| 29.5
|
white
| 33.398438
| 49
| 0.593994
| 0.484985
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 42
| 48
| 8.199219
| 122
| 30
| 38.79688
| 114.28125
| null | null | 1.099854
| 135
| 7.389648
| null | null | null | null | 0
| null | 0
| 1,519
| 0
|
69.69495
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 9
| 7,717
| 5,093.1133
| 4,697.60938
| 13
|
white
| 10.199219
| 16
| 0.915894
| 0.85791
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
dnr after sadm
| 1
| 103
| 6.299805
| 70
| 24
| 37
| 266.625
| 4.099609
| 0.899902
| 1
| 144
| 7.369141
| null | null | null | null | 0
| null | 0
| 1,520
| 0
|
83.95599
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 7
|
$11-$25k
| 0
| 8,863
| 5,815.418
| 5,512.26953
| 14.5
|
white
| 24.898438
| 48
| 0.714966
| 0.556885
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 13
| 108
| 10.298828
| 140
| 40
| 36.69531
| 304
| null | null | 1.599854
| 137
| 7.449219
| null | null | null | 0
| 0
| null | 0
| 122
| 1
|
74.33496
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
$11-$25k
| 0
| 25,606
| 16,679.2188
| 13,997.1875
| 20.666656
|
white
| 32.195313
| 65
| 0.564941
| 0.452942
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 60
| 12.398438
| 70
| 32
| 36.19531
| 163.3125
| 2.899902
| 4.299805
| 4
| 141
| 7.539062
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 185
| 1
|
59.32898
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 11
|
$25-$50k
| 0
| 25,116
| 16,730.25
| 15,839.3594
| 41
|
white
| 35.898438
| 71
| 0.305969
| 0.19397
| 8
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 6
| 77
| 0.099991
| 150
| 30
| 39.19531
| 210.1875
| 2.399902
| 1.399902
| 2.399902
| 142
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
67.86896
|
female
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 24,268
| 17,109
| 16,699.4375
| 27
|
white
| 30.296875
| 56
| 0.694946
| 0.529907
| 1
| 0
| 0
|
no
| 0.5
| 0.45
|
no dnr
| 18
| 103
| 6.199219
| 132
| 76
| 36.19531
| null | 3.399902
| 0.799927
| 2.599609
| 141
| null | null | null | null | 3
| 2
|
no(M2 and SIP pres)
| 2
| 1,517
| 0
|
84.95599
|
female
| 0
| 26
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 28,041
| 17,552.5156
| 18,137.8594
| 16.5
|
white
| 17.898438
| 28
| 0.762939
| 0.510986
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.125
|
no dnr
| 26
| 66
| 25.699219
| 63
| 22
| 36.5
| null | null | 1.099854
| 1
| 137
| null | null | null | null | null | null | null | 2.9375
| 235
| 1
|
77.95496
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 0
| 19,490
| 12,830.0469
| 12,229.8984
| 14
|
white
| 22
| 39
| 0.791992
| 0.723999
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 1
| 114
| 9.898438
| 78
| 20
| 36.39844
| 260
| 4.399414
| 0.599976
| 3.199707
| 146
| 7.40918
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 851
| 1
|
54.086
|
female
| 1
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 55
| 90,082
| 59,675.3438
| 63,244.0312
| 32.75
|
white
| 33.898438
| 34
| 0.362
| 0.244995
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 17
| 62
| 4.599609
| 110
| 12
| 39.79688
| 93.75
| 2.799805
| 0.799927
| 0.699951
| 151
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 2.555664
| 36
| 1
|
76.55597
|
male
| 1
| 15
|
Colon Cancer
|
Cancer
| 3
| 8
|
$11-$25k
| 0
| 9,715
| 6,996.0273
| 7,081.45703
| 7.333332
|
white
| 20.097656
| 22
| 0.744995
| 0.481995
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 137
| 9.398438
| 81
| 20
| 35.89844
| 347.5625
| 3.199707
| 1
| 0.899902
| 134
| 7.469727
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 15
| 1
|
37.63397
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
>$50k
| 0
| 5,411
| 3,474.9941
| 2,746.17969
| 19
|
white
| 20.296875
| 21
| 0.919922
| 0.86499
| 1
| 0
| 0
|
no
| 0.5
| 0.7
|
no dnr
| 7
| 71
| null | 150
| 24
| 36.19531
| null | null | null | 1
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,510
| 0
|
79.57599
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 7
|
under $11k
| 0
| 3,169
| 2,122.8106
| 2,010.43945
| 12
|
white
| 21
| 19
| 0.576904
| 0.255981
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 1
| 69
| 8.699219
| 106
| 24
| 36.5
| null | 3.199707
| 0.299988
| 0.799927
| 136
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.426758
| 48
| 1
|
84.51495
|
male
| 0
| 7
|
Coma
|
Coma
| 7
| 8
|
under $11k
| 61
| 7,884
| null | null | 10.5
|
white
| 25.796875
| 39
| 0.098999
| 0.058998
| 1
| 1
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 1
| 116
| 17.199219
| 114
| 34
| 38.79688
| 192.5
| 4
| 0.399963
| 1.899902
| 135
| 7.399414
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 14
| 1
|
86.58698
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 5,752
| 3,898.1152
| 3,460.0293
| 10.5
|
white
| 17.796875
| 31
| 0.81897
| 0.705933
| 1
| 0
| 0
|
no
| 0.5
| 0.1
|
no dnr
| 8
| 79
| 6.799805
| 64
| 20
| 35.79688
| 295.1875
| null | null | 0.899902
| 134
| 7.459961
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 235
| 1
|
89.06494
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
under $11k
| 0
| 1,830
| 1,201.4512
| 1,016.43994
| 14
|
white
| 19.296875
| 28
| 0.787964
| 0.659912
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 77
| 12.599609
| 63
| 28
| 35.89844
| 468
| null | null | 1
| 140
| 7.299805
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 319
| 1
|
59.18997
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 6
|
$25-$50k
| 94
| 33,846
| 21,978.1562
| 24,646.2188
| 33
|
white
| 25.296875
| 45
| 0.123993
| 0.054993
| 18
| 1
| 0
|
yes
| null | null |
no dnr
| 5
| 72
| 12.5
| 113
| 32
| 38.69531
| 195.90625
| 2.399902
| 0.199982
| 1.799805
| 149
| 7.339844
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 5
| 1
|
60.87598
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 6,616
| 4,464.9961
| 4,013.96875
| 7.5
|
white
| 22.5
| 35
| 0.838989
| 0.783936
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 8
| 119
| 7.199219
| 125
| 22
| 36.39844
| 300
| 4.299805
| 0.5
| 1.899902
| 139
| 7.40918
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,504
| 0
|
71.81396
|
male
| 1
| 7
|
Lung Cancer
|
Cancer
| 2
| 13
|
$25-$50k
| 0
| 3,552
| 2,271.9121
| 2,224.57812
| 12
|
white
| 22.597656
| 34
| 0.560913
| 0.238983
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 111
| 7.799805
| 130
| 36
| 36.29688
| null | 3.699707
| 0.799927
| 1.099854
| 130
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.407715
| 7
| 1
|
67.37897
|
male
| 1
| 24
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 34,907
| 23,411.4688
| 22,419.8281
| 20
|
white
| 22.199219
| 27
| 0.78894
| 0.661987
| 6
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 24
| 60
| null | 106
| 26
| 37.69531
| 155
| null | null | 1.299805
| 140
| 7.349609
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 24
| 1
|
61.50897
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 7,431
| 5,242.8906
| 4,630
| 10
|
white
| 10.599609
| 24
| 0.937988
| 0.893921
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 61
| 10.298828
| 79
| 20
| 36.09375
| null | 4.5
| 0.799927
| 1.299805
| 135
| null | null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 998
| 1
|
68.78595
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 4
| 8
|
under $11k
| 9
| 4,051
| 2,365.6758
| 1,519.08984
| 11
|
white
| 18
| 41
| 0.641968
| 0.333984
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 1
| 113
| 7.5
| 98
| 28
| 35.29688
| null | 4.099609
| 0.599976
| 2.099609
| 134
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.737793
| 185
| 1
|
49.89499
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
under $11k
| 0
| 7,770
| 5,283.8047
| 6,033.08984
| 32
|
white
| 23.398438
| 34
| 0.858887
| 0.809937
| 1
| 1
| 0
|
no
| 1
| 1
|
no dnr
| 7
| 120
| 21.898438
| 133
| 22
| 38
| null | 2.799805
| 0.599976
| 1.799805
| 147
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 1,495
| 0
|
69.40198
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 25,649
| 17,458.9375
| 14,941.2891
| 18.5
|
white
| 30.199219
| 40
| 0.605957
| 0.5
| 8
| 1
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 12
| 71
| 24
| 96
| 24
| 37.69531
| 118.35938
| null | null | 4.399414
| 137
| 7.379883
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,133
| 1
|
73.17499
|
male
| 1
| 22
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 42,914
| 28,734.4531
| 30,136.5156
| 40.333313
|
white
| 27.796875
| 54
| 0.534912
| 0.419983
| 5
| 0
| 0
|
yes
| 0.9
| 0.9
|
dnr after sadm
| 13
| 57
| 9.798828
| 160
| 14
| 38.29688
| 203.3125
| 2.599609
| 6.099609
| 1
| 133
| 7.469727
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
85.41296
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
|
under $11k
| 0
| 13,014
| 8,535.0312
| 8,705.04688
| 16
|
white
| 30.199219
| 54
| 0.439941
| 0.319946
| 5
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 69
| 15.5
| 112
| 28
| 36.69531
| 125.70312
| null | null | 1.699951
| 143
| 7.55957
| null | null | null | null | null | null | 3.962891
| 1,012
| 1
|
66.71899
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 3,790
| 2,324.3262
| 2,037.11914
| 8
|
white
| 12.398438
| 18
| 0.785889
| 0.550903
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 5
| 106
| 6.199219
| 114
| 24
| 37.5
| null | 3.899902
| 0.299988
| 0.899902
| 138
| null | null | null | null | null | null | null | 2.019531
| 372
| 1
|
69.44299
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| null | null | 0
| 8,271
| 5,386.6602
| 8,312.35938
| 14.5
|
other
| 17.699219
| 32
| 0.795898
| 0.671997
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 11
| 104
| 10
| 83
| 40
| 37.59375
| 280.9375
| 3.399902
| 0.099991
| 0.799927
| 133
| 7.359375
| null | null | null | null | null | null | 4.601563
| 405
| 1
|
70.64795
|
female
| 0
| 14
|
Coma
|
Coma
| 0
| 12
|
$25-$50k
| 100
| 12,994
| 8,343.4141
| 8,123.11719
| 20.333328
|
white
| 24
| 44
| 0.156982
| 0.103989
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 1
| 121
| 28.5
| 138
| 40
| 38.19531
| 220.40625
| 4.5
| 0.699951
| 1.299805
| 138
| 7.539062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 15
| 1
|
64.35596
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 9,355
| 5,870.8125
| 5,610.50781
| 12
|
white
| 19.199219
| 21
| 0.866943
| 0.819946
| 1
| 0
| 0
|
no
| 0.99
| 0.9
|
no dnr
| 7
| 103
| 9.898438
| 58
| 24
| 36.59375
| 325.875
| 4.099609
| 0.599976
| 1.5
| 133
| 7.429688
| null | null | null | null | null | null | 2.389648
| 1,489
| 0
|
56.54498
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 2,563
| 1,645.4492
| 1,407.18945
| 13
|
white
| 20.398438
| 15
| 0.656982
| 0.352966
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 3
| 104
| null | 79
| 20
| 36
| null | null | 0.399963
| 1
| 125
| null | null | null | null | null | null | null | 2.131348
| 664
| 1
|
68.68994
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 9,280
| 5,733.3477
| 6,112.65625
| 19
|
white
| 20.5
| 32
| 0.840942
| 0.786987
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 5
| 77
| 16.398438
| 79
| 25
| 36.19531
| 242.84375
| 4
| 0.599976
| 1.699951
| 137
| 7.419922
| null | null | null | null | null | null | 1.833496
| 1,484
| 0
|
57.30899
|
male
| 0
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 59,005
| 38,558.0625
| 46,547
| 32.666657
|
white
| 21.296875
| 41
| 0.728882
| 0.644897
| 3
| 0
| 0
|
yes
| 0.05
| 0.000125
|
dnr after sadm
| 15
| 52
| 9.699219
| 76
| 32
| 39.09375
| 196.65625
| 2.599609
| 0.399963
| 1.199951
| 138
| 7.459961
| null | null | null | 2
| 0
|
<2 mo. follow-up
| 0
| 20
| 1
|
73.78796
|
female
| 0
| 114
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 116,672
| 82,243.5625
| 78,932.1875
| 19
|
white
| 35.5
| 43
| 0.444946
| 0.324951
| 6
| 0
| 1
|
no
| null | null |
dnr after sadm
| 39
| 44
| 16.398438
| 102
| 28
| 38.89844
| 150
| null | null | 1.5
| 137
| 7.459961
| null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 540
| 1
|
54.28299
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 11
|
under $11k
| 0
| 15,432
| 10,693.2188
| 10,255.8594
| 30
|
white
| 14.199219
| 17
| 0.929932
| 0.879883
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 12
| 68
| 8.599609
| 65
| 22
| 38.29688
| null | 3.299805
| 1
| 1.199951
| 139
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,483
| 0
|
72.849
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 14
|
under $11k
| 0
| 5,383
| 3,525.8086
| 4,021.81836
| 7
|
white
| 9.199219
| 35
| 0.92395
| 0.870972
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 9
| 67
| 18.5
| 70
| 24
| 37.69531
| 239.125
| 4.599609
| 0.299988
| 1.5
| 137
| 7.369141
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.691406
| 1,480
| 0
|
71.81897
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 16
|
under $11k
| 0
| 4,949
| 3,180.9316
| 3,546.20898
| 7
|
white
| 11.798828
| 24
| 0.785889
| 0.550903
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.9
|
no dnr
| 6
| 78
| 9.298828
| 85
| 20
| 36.39844
| null | 3.799805
| 0.399963
| 1.199951
| 134
| null | null | null | null | null | null | null | 2.199219
| 879
| 1
|
76.46497
|
female
| 0
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 16
|
under $11k
| 0
| 16,170
| 11,200.375
| 11,975.1328
| 11.5
|
white
| 21.097656
| 31
| 0.656982
| 0.47998
| 1
| 1
| 0
|
no
| 1
| 1
|
dnr after sadm
| 10
| 85
| 7.099609
| 92
| 20
| 36.39844
| 338.0625
| 2.799805
| 2.799805
| 1.699951
| 132
| 7.489258
| null | null | null | 1
| null |
<2 mo. follow-up
| 1.1669
| 17
| 1
|
53.72998
|
male
| 0
| 26
|
Coma
|
Coma
| 4
| 11
|
>$50k
| 94
| 47,203
| 31,308.5312
| 35,985.875
| 28.25
|
white
| 26.699219
| 38
| 0.269958
| 0.201996
| 1
| 0
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 15
| 57
| 34.59375
| 108
| 12
| 39.19531
| 180
| 4.5
| 0.5
| 1.299805
| 133
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
59.44998
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 7,654
| 4,569.625
| 5,112.92969
| 9
|
white
| 14.398438
| 12
| 0.85791
| 0.682983
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.4
|
no dnr
| 7
| 75
| null | 65
| 20
| 36.69531
| null | null | null | null | 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 439
| 1
|
92.53894
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 5,446
| 3,765.416
| 4,130.79688
| 4
|
hispanic
| 19.398438
| 37
| 0.770996
| 0.635986
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 78
| 7.399414
| 70
| 20
| 36.39844
| 252.375
| null | null | 2.399902
| 140
| 7.439453
| null | null | null | null | 5
|
no(M2 and SIP pres)
| 5
| 234
| 1
|
59.556
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 8
|
under $11k
| 0
| 4,463
| 2,632.8672
| 1,954.90918
| 11
|
white
| 14.898438
| 22
| 0.758911
| 0.504883
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 77
| 5.099609
| 74
| 24
| 36.29688
| null | null | 0.299988
| 1.399902
| 137
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.958984
| 389
| 1
|
42.965
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 0
| 125,903
| 78,030.25
| 85,739.0625
| 42
|
white
| 40
| 55
| 0.514893
| 0.398987
| 8
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 28
| 43
| 19.5
| 138
| 36
| 38.79688
| 235
| null | null | 3
| 144
| 7.529297
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 28
| 1
|
63.25
|
female
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 37
| 30,327
| 21,310.875
| 20,660.6875
| 24.333328
|
white
| 40.09375
| 74
| 0.245972
| 0.142975
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 22
| 43
| 23.5
| 146
| 40
| 38.39844
| 203.3125
| null | null | 2.199707
| 134
| 7.25
| null | null | null | null | 0
| null | 0
| 1,469
| 0
|
78.04797
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
under $11k
| 26
| 21,947
| 14,963.3359
| 15,439.25
| 24.5
|
other
| 23.5
| 34
| 0.501953
| 0.384949
| 7
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 5
| 68
| 4.699219
| 66
| 12
| 36.29688
| 250
| null | 0.699951
| 7.099609
| 140
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
80.08997
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 15
|
$11-$25k
| 0
| 3,531
| 2,403.7617
| 2,434.28906
| 7
|
white
| 10.599609
| 33
| 0.891968
| 0.81897
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
dnr after sadm
| 1
| 71
| 10.798828
| 87
| 16
| 36
| 223.78125
| 4.899414
| 0.799927
| 0.799927
| 139
| 7.419922
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.409668
| 1,373
| 1
|
61.60999
|
male
| 1
| 6
|
Coma
|
Coma
| 1
| 14
|
$11-$25k
| 100
| 3,837
| 2,556.6562
| 2,668.53906
| 19
|
white
| 18.796875
| 27
| 0.390991
| 0.316956
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 111
| 14.199219
| 101
| 28
| 38.59375
| 422.5
| 4.599609
| 0.5
| 1.399902
| 142
| 7.30957
| null | null | null | null | null |
<2 mo. follow-up
| 2.325684
| 6
| 1
|
72.59998
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 7,230
| 4,681.4297
| 4,973.36719
| 7.5
|
white
| 19
| 31
| 0.839966
| 0.736938
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr before sadm
| -1
| 67
| 14
| 104
| 32
| 36.09375
| 232
| 3.799805
| 0.699951
| 1.199951
| 141
| 7.379883
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 739
| 1
|
90.26697
|
female
| 0
| 16
|
Coma
|
Coma
| 4
| 8
|
under $11k
| 44
| 8,338
| 5,678.207
| 4,818.97656
| 5.666664
|
white
| 23
| 43
| 0.262939
| 0.195984
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 16
| 113
| 27.398438
| 107
| 24
| 38.59375
| null | 3.599609
| 0.699951
| 2
| 134
| null | null | null | null | null | null |
<2 mo. follow-up
| 5.351563
| 20
| 1
|
63.18698
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| 8
|
under $11k
| 0
| 3,640
| 2,633.0938
| 2,440.39844
| 9
|
white
| 8
| 9
| 0.848999
| 0.666992
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 2
| 83
| null | 101
| 24
| 36.5
| null | 4.199219
| 0.399963
| 1
| 140
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 345
| 1
|
50.71298
|
male
| 1
| 5
|
Coma
|
Coma
| 0
| 10
| null | 0
| 14,165
| 9,191.4375
| 9,033.46875
| 29
|
white
| 18.597656
| 7
| 0.850952
| 0.820923
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 117
| 18.796875
| 72
| 24
| 38.59375
| 163.25
| null | null | 0.899902
| 138
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 1.468506
| 5
| 1
|
63.33499
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
| null | 0
| 10,998
| 7,141.5117
| 6,555.09766
| 14.5
|
white
| 22.199219
| 36
| 0.841919
| 0.741943
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 59
| 10.5
| 39
| 20
| 36.39844
| null | null | null | 1.5
| 138
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,138
| 1
|
76.34796
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 10
|
under $11k
| 0
| 4,317
| 2,808.6426
| 2,515.12891
| 11
|
white
| 19.597656
| 22
| 0.620972
| 0.306946
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 6
| 103
| 5.799805
| 122
| 20
| 36.79688
| null | 3.399902
| 0.099991
| 0.799927
| 138
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.441895
| 198
| 1
|
78.24799
|
female
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 8,286
| 5,489.4648
| 5,500.75781
| 5
|
white
| 22.097656
| 27
| 0.761963
| 0.621948
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 13
| 107
| 6.099609
| 71
| 28
| 36.29688
| 271.375
| 3.399902
| 0.299988
| 0.599976
| 128
| 7.379883
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,456
| 0
|
62.185
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
|
>$50k
| 37
| 104,716
| 71,111
| 72,206.6875
| 38
|
white
| 42.898438
| 77
| 0.095993
| 0.038994
| 42
| 0
| 0
|
no
| 0.2
| 0.008
|
dnr after sadm
| 1
| 53
| 35.09375
| 70
| 28
| 34.39844
| 137.5
| 3.299805
| 5
| 6.299805
| 136
| 7.349609
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
78.42798
|
female
| 0
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 63,652
| 43,971.6875
| 41,493.0938
| 19.5
|
white
| 26.898438
| 35
| 0.504883
| 0.387939
| 11
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 81
| 22.5
| 128
| 26
| 38.29688
| 351.375
| null | null | 2.699707
| 137
| 7.449219
| null | null | null | null | null | null | 2.589844
| 1,455
| 0
|
42.38998
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
$11-$25k
| 0
| 56,976
| 37,833.6562
| 44,572.6562
| 24.25
|
white
| 33.398438
| 72
| 0.743896
| 0.66394
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 37
| 54
| 11.5
| 160
| 50
| 40
| 188.5625
| 2.099609
| 0.599976
| 0.899902
| 150
| 7.389648
| null | null | null | null | 2
|
no(M2 and SIP pres)
| 2
| 1,455
| 0
|
53.34698
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 3
| 12
|
$25-$50k
| 0
| 3,856
| 2,521.207
| 2,108.17969
| 8
|
white
| 23.796875
| 18
| 0.585938
| 0.265991
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 5
| 109
| 12.599609
| 122
| 20
| 36.19531
| null | null | 0.299988
| 0.699951
| 132
| null | null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 160
| 1
|
58.90997
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 0
| 7,424
| 4,781.4648
| 5,585.58984
| 9
|
white
| 15.898438
| 32
| 0.918945
| 0.863892
| 1
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 9
| 75
| 11.099609
| 66
| 24
| 36.29688
| 204.75
| 3.799805
| 0.5
| 0.899902
| 143
| 7.439453
| null | null | null | 1
| 2
|
no(M2 and SIP pres)
| 2
| 55
| 1
|
85.94696
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 16
|
under $11k
| 0
| 7,914
| 5,262.6758
| 5,151.19922
| 8.5
|
white
| 17.296875
| 30
| 0.784912
| 0.655884
| 1
| 1
| 1
|
no
| 1
| 1
|
no dnr
| 11
| 60
| 8.199219
| 79
| 24
| 35.89844
| null | null | 0.5
| 1.199951
| 131
| null | null | null | null | null | null |
Coma or Intub
| 4.84375
| 127
| 1
|
22.55699
|
male
| 0
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 13
|
under $11k
| 0
| 17,616
| 12,264.8516
| 9,851.84375
| 41
|
white
| 38.195313
| 57
| 0.403992
| 0.284973
| 1
| 0
| 0
|
yes
| 0.01
| 0.000001
|
dnr after sadm
| 5
| 114
| 2.5
| 146
| 36
| 39.59375
| 304.75
| 2.799805
| 0.799927
| 2.199707
| 125
| 7.479492
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 6
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.